Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Advances in cataract surgery driven by technology
The new modified prolate IOL (Tecnis Z9000, Pfizer) may have ushered in a new era in the design of IOLs, suggested speakers at a recent symposium on advances in cataract surgery. The aspherical design used in the Tecnis lens could become the standard within a few years, and, along with new viscoelastic or viscoadaptive devices, should enable surgeons to achieve better results from cataract surgery.
Related Videos
Related Content
